SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-21-043637
Filing Date
2021-08-18
Accepted
2021-08-18 16:10:47
Documents
3
Effectiveness Date
2021-08-18

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea145918-s8_nektarthera.htm S-8 63356
2 OPINION OF GOODWIN PROCTER LLP WITH RESPECT TO THE VALIDITY OF THE SECURITIES ea145918ex5-1_nektarthera.htm EX-5.1 5173
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea145918ex23-1_nektarthera.htm EX-23.1 1948
  Complete submission text file 0001213900-21-043637.txt   71680
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-258900 | Film No.: 211186788
SIC: 2834 Pharmaceutical Preparations